Skip to main content

AS/Spondyloarthritis

      RT @doctorRBC: GM-CSF increased in patients with active ankylosing spondylitis, correlates with disease activity, not du
      2 years 5 months ago
      GM-CSF increased in patients with active ankylosing spondylitis, correlates with disease activity, not duration. TNFi does not affect GM-CSF levels. Could explain efficacy of JAKinibs and response for residual inflammation during TNF blockade. @RheumNow #EULAR2022 ABST#OP0107
      RT @synovialjoints: Depression was the most prevalent comorbidity (31%), hypertension (26%) and uveitis the most common
      2 years 5 months ago
      Depression was the most prevalent comorbidity (31%), hypertension (26%) and uveitis the most common EMM (30%) in AS from the PSOAS cohort by @rheum_cat . Five clusters identified with depression and hypertension groups having higher disease activity #EULAR2022 @RheumNow OP0154 https://t.co/dpqaFD4Qzw
      JAKi for nonradiographic axSpA

      One area of continued interest for many rheumatologists is the field of non-radiographi
      2 years 5 months ago
      JAKi for nonradiographic axSpA One area of continued interest for many rheumatologists is the field of non-radiographic axial spondyloarthritis. And the question of the utility of JAK inhibitors for the treatment of axSpA has been on the rise. https://t.co/xq8ICyKKv0 https://t.co/o2iUgyU60A
      RT @AurelieRheumo: 💫Trajectory analysis in SpA💫

      Data on 1,125 patients
      Prediction of spinal radiographic progress
      2 years 5 months ago
      💫Trajectory analysis in SpA💫 Data on 1,125 patients Prediction of spinal radiographic progression ⭐️FAST associated w/ onset at older age & 👁involvement ⭐️SLOW progression associated w/ female gender & peripheral involvement. #EULAR2022 @RheumNow OP0151 https://t.co/E80qCLEtBv
      RT @RichardPAConway: Comorbidity in AS from @rheum_cat , Karmacharya et al. Clustering of comorbidities. Depression and
      2 years 5 months ago
      Comorbidity in AS from @rheum_cat , Karmacharya et al. Clustering of comorbidities. Depression and hypertension clusters assoc worse disease activity and function @RheumNow #EULAR2022 OP0154 https://t.co/jGQXayAYs9 https://t.co/SnVDhVYQq5
      RT @ericdeinmd: #EULAR2022 ASAS/EULAR AxSpA Recs
      ⭐️Last: 2016
      ▶️All: education, exercise, 🚭
      ▶️❌csDMARD
      2 years 5 months ago
      #EULAR2022 ASAS/EULAR AxSpA Recs ⭐️Last: 2016 ▶️All: education, exercise, 🚭 ▶️❌csDMARD for axial disease ▶️TNF/IL17 (or JAK) with high disease: ASDAS>/=2.1 ▶️Monoclonal TNF for uveitis/IBD, high PsO: IL-17 ▶️Sustained remission: tapering of bDMARD "can be considered" @RheumNow https://t.co/3yYU0Vb37r
      RT @RichardPAConway: Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. M
      2 years 5 months ago
      Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. Multivariate model, age (HR 1.22 (1.08-1.40)) and preconception NSAID use (HR 3.01 (2.15-3.85)) assoc increase time to conception. @RheumNow #EULAR2022 OP0153 https://t.co/y2EAyAdRmk https://t.co/28aLimRInE
      RT @synovialjoints: The PROOF study showed the predictors of radiographic progression included male gender HR 3.16, good
      2 years 5 months ago
      The PROOF study showed the predictors of radiographic progression included male gender HR 3.16, good response to NSAIDs HR 4.66, fulfillment of the imaging arm HR 6.64 and HLA-B27+ HR 3.99 by Poddubnyy et al #EULAR2022 @RheumNow OP0149
      RT @synovialjoints: The GESPIC cohort reports in Axial PsA, 75% had inflammatory back pain, 45% met NY criteria for AS,
      2 years 5 months ago
      The GESPIC cohort reports in Axial PsA, 75% had inflammatory back pain, 45% met NY criteria for AS, 55% with active inflammatory change in SI joint and 60% in the spine. This is where the overlap between Axial PsA and Axial SpA happens, Kading et al #EULAR2022 @RheumNow OP0026
      RT @AurelieRheumo: Pregnancy outcomes in SpA
      Increased risk of
      ❗️gestational diabetes aRR 1.88
      ❗️Cesarean del
      2 years 5 months ago
      Pregnancy outcomes in SpA Increased risk of ❗️gestational diabetes aRR 1.88 ❗️Cesarean delivery aRR 1.54 & 1.23 ❗️preterm birth aRR 1.52 ❗️trend for increased infection in 1st year of life in newborns aRR 1.23. #EULAR2022 @RheumNow OP0126 https://t.co/jMryB5UXQr